Поиск по каталогу |
(строгое соответствие)
|
- Профессиональная
- Научно-популярная
- Художественная
- Публицистика
- Детская
- Искусство
- Хобби, семья, дом
- Спорт
- Путеводители
- Блокноты, тетради, открытки
Counterfeit Pharmaceuticals. Are the U.S. Consumers Aware of the Potential Risks?
В наличии
Местонахождение: Алматы | Состояние экземпляра: новый |
Бумажная
версия
версия
Автор: Mark Willis
ISBN: 9786200276162
Год издания: 2019
Формат книги: 60×90/16 (145×215 мм)
Количество страниц: 248
Издательство: LAP LAMBERT Academic Publishing
Цена: 47794 тг
Положить в корзину
Способы доставки в город Алматы * комплектация (срок до отгрузки) не более 2 рабочих дней |
Самовывоз из города Алматы (пункты самовывоза партнёра CDEK) |
Курьерская доставка CDEK из города Москва |
Доставка Почтой России из города Москва |
Аннотация: The presence of counterfeits in the pharmaceutical product market is an increasing risk that places consumers in potential harm, or in some cases, even results in death. While the United States Food and Drug Administration has taken steps to mitigate the risk of counterfeit pharmaceuticals from entering the supply chain, consumers are in the dark regarding the growing dangers that they face. The intent of this book was to determine the overall level of understanding of the U.S. consumer regarding the risk of counterfeit pharmaceuticals to their long-term health and well-being. The findings determined that these respondents did not fully understand what defined a counterfeit pharmaceutical nor did they have a high level of understanding of the risk that exists within the United States. The risk of counterfeit pharmaceuticals in the United States may be relatively low compared to the rest of the world, but the risk does still exist. Counterfeit pharmaceuticals will continue to flourish within the United States without a formalized communication policy which will educate consumers regarding the potential risk to their health and long term well-being.
Ключевые слова: Counterfeit drugs, Counterfeits, pharmaceuticals, consumer knowledge, Drugs, Falsified Drugs, Counterfeit Pharmaceuticals, FDA